Phenylpropanoid glycosides from Rhodiola rosea

82Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Rhodiola rosea L. (Golden Root) has been used for a long time as an adaptogen in Chinese traditional medicine and is reported to have many pharmacological properties. Along its known secondary metabolites tyrosol (1), salidroside (rhodioloside) (2), rosin (3), rosarin (4), rosavin (5), sachaliside 1 (6) and 4-methoxy-cinnamyl-O-β-D-glucopyranoside (7), four compounds were isolated from aqueous methanol extract of the plant and identified as cinnamyl-(6′-O-β-xylopyranosyl)-O-β-glucopyranoside (8), 4-methoxy-cinnamyl-(6′-O-α-arabinopyranosyl)-O-β- glucopyranoside (9), picein (10) and benzyl-O-β-glucopyranoside (11) by UV, MS and NMR methods. Compounds 8 and 9 are new natural compounds whereas compounds 10 and 11 were isolated first time from R. rosea. Also the compounds 6 and 7 are isolated earlier only from the callus cultures of the plant but not from the differentiated plant. © 2003 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Tolonen, A., Pakonen, M., Hohtola, A., & Jalonen, J. (2003). Phenylpropanoid glycosides from Rhodiola rosea. Chemical and Pharmaceutical Bulletin, 51(4), 467–470. https://doi.org/10.1248/cpb.51.467

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free